Tag: cell and gene therapies

Cell and Gene Therapy CROs: The Next Growth Opportunity

Over the years, cell and gene therapy (CGT) and other advanced therapy medicinal products (ATMPs) have managed to capture the interest of both drug developers and healthcare investors. Their popularity can be attributed to various factors, such as minimal side effects, clinical efficacy and their personalized nature. However, there are several complexities associated with the

Bioassay Services – A Prerequisite for the ATMPs Development

Bioassay Services – A Prerequisite for the Cell and Gene Therapy Development Over the past few years, investigational new drug (IND) filings by cell and gene therapy companies have significantly increased. In fact, from year 2016 to 2020 more than 300 IND filing for cell and gene therapy product have been recorded, indicating that several